Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Identification of a molecular subtyping system associated with the prognosis of Asian hepatocellular carcinoma patients receiving liver resection.

Ma X, Gu J, Wang K, Zhang X, Bai J, Zhang J, Liu C, Qiu Q, Qu K.

Sci Rep. 2019 May 8;9(1):7073. doi: 10.1038/s41598-019-43548-1.

2.

Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.

Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K.

World J Gastroenterol. 2019 Jan 14;25(2):220-232. doi: 10.3748/wjg.v25.i2.220.

3.

[A new prognostic score system of hepatocellular carcinoma following hepatectomy].

Wang YK, Bi XY, Li ZY, Zhao H, Zhao JJ, Zhou JG, Huang Z, Zhang YF, Li MX, Chen X, Wu XL, Mao R, Hu XH, Hu HJ, Liu JM, Cai JQ.

Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005. Chinese.

PMID:
29262506
4.

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.

Liu GM, Zeng HD, Zhang CY, Xu JW.

Cancer Cell Int. 2019 May 21;19:138. doi: 10.1186/s12935-019-0858-2. eCollection 2019.

5.

A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction.

Wang Z, Teng D, Li Y, Hu Z, Liu L, Zheng H.

Life Sci. 2018 Jun 15;203:83-91. doi: 10.1016/j.lfs.2018.04.025. Epub 2018 Apr 17.

PMID:
29678742
6.

A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.

Chen PF, Li QH, Zeng LR, Yang XY, Peng PL, He JH, Fan B.

J Cell Biochem. 2019 Jun;120(6):9117-9124. doi: 10.1002/jcb.28187. Epub 2018 Dec 23.

PMID:
30582205
7.

Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma.

Xiang XH, Yang L, Zhang X, Ma XH, Miao RC, Gu JX, Fu YN, Yao Q, Zhang JY, Liu C, Lin T, Qu K.

World J Gastroenterol. 2019 Apr 14;25(14):1715-1728. doi: 10.3748/wjg.v25.i14.1715.

8.

Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification.

Ke K, Chen G, Cai Z, Huang Y, Zhao B, Wang Y, Liao N, Liu X, Li Z, Liu J.

Cancer Manag Res. 2018 Nov 5;10:5291-5302. doi: 10.2147/CMAR.S178579. eCollection 2018.

9.

High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.

Lv Y, Wang W, Jia WD, Sun QK, Huang M, Zhou HC, Xia HH, Liu WB, Chen H, Sun SN, Xu GL.

Eur J Surg Oncol. 2013 Oct;39(10):1129-35. doi: 10.1016/j.ejso.2013.06.023. Epub 2013 Jul 31.

PMID:
23916473
10.
11.

Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.

Zhao QJ, Zhang J, Xu L, Liu FF.

World J Gastroenterol. 2018 Aug 14;24(30):3426-3439. doi: 10.3748/wjg.v24.i30.3426.

12.

Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma.

Zheng Y, Liu Y, Zhao S, Zheng Z, Shen C, An L, Yuan Y.

Cancer Manag Res. 2018 Nov 21;10:6079-6096. doi: 10.2147/CMAR.S181396. eCollection 2018.

13.

Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.

Zhang XF, Yin ZF, Wang K, Zhang ZQ, Qian HH, Shi LH.

Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):618-23.

PMID:
23232633
14.
15.

Clinical parameters outperform molecular subtypes for predicting outcome in bladder cancer: Results from multiple cohorts including TCGA.

Morera DS, Lahorewala SS, Belew D, Ghosh S, Klaassen Z, Jordan AR, Wang J, Terris MK, Bollag RJ, Merseburger AS, Stenzl A, Soloway MS, Lokeshwar VB.

J Urol. 2019 May 21:101097JU0000000000000351. doi: 10.1097/JU.0000000000000351. [Epub ahead of print]

PMID:
31112107
16.

New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.

Gan W, Huang JL, Zhang MX, Fu YP, Yi Y, Jing CY, Fan J, Zhou J, Qiu SJ.

J Surg Oncol. 2018 Jun;117(7):1540-1547. doi: 10.1002/jso.25046. Epub 2018 Mar 24.

PMID:
29572833
17.

Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.

Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS.

World J Gastroenterol. 2002 Apr;8(2):237-42.

18.

Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.

Kamiyama T, Orimo T, Wakayama K, Shimada S, Nagatsu A, Yokoo H, Kamachi H, Yamashita K, Shimamura T, Taketomi A.

World J Surg Oncol. 2017 Aug 22;15(1):156. doi: 10.1186/s12957-017-1229-x.

19.

Identification of a four-gene metabolic signature predicting overall survival for hepatocellular carcinoma.

Liu GM, Xie WX, Zhang CY, Xu JW.

J Cell Physiol. 2019 Jul 16. doi: 10.1002/jcp.29081. [Epub ahead of print]

PMID:
31309563
20.

Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.

Xieraili M, Yasen M, Mogushi K, Obulhasim G, Mayinuer A, Aihara A, Tanaka S, Mizushima H, Tanaka H, Arii S.

Cancer Sci. 2012 Aug;103(8):1493-501. doi: 10.1111/j.1349-7006.2012.02315.x. Epub 2012 May 25.

Supplemental Content

Support Center